Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Jiang Wei

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Medcomm|April 3, 2026
Metabolic Alterations in Macrophage Subtypes Propel Immune and Stromal Remodeling in Neurofibroma's Malignant ProgressionLing-Ling Ge, Yue-Hua Li, Xuan Yu, et al.
The Journal of Investigative Dermatology|September 17, 2021
Combined Cyclin-Dependent Kinase Inhibition Overcomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type IWei Wang, Xi-Wei Cui, Yi-Hui Gu, et al.
NPJ Digital Medicine|January 25, 2025
A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identificationCheng-Jiang Wei, Yan Tang, Yang-Bai Sun, et al.
Frontiers in Oncology|August 28, 2020
Computed Tomography-Based Differentiation of Benign and Malignant Craniofacial Lesions in Neurofibromatosis Type I Patients: A Machine Learning ApproachCheng-Jiang Wei, Cheng Yan, Yan Tang, et al.
Neuro-Oncology Advances|July 10, 2020
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesisCheng-Jiang Wei, Shu-Chen Gu, Jie-Yi Ren, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Medcomm|April 3, 2026
Metabolic Alterations in Macrophage Subtypes Propel Immune and Stromal Remodeling in Neurofibroma's Malignant ProgressionLing-Ling Ge, Yue-Hua Li, Xuan Yu, et al.
The Journal of Investigative Dermatology|September 17, 2021
Combined Cyclin-Dependent Kinase Inhibition Overcomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type IWei Wang, Xi-Wei Cui, Yi-Hui Gu, et al.
NPJ Digital Medicine|January 25, 2025
A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identificationCheng-Jiang Wei, Yan Tang, Yang-Bai Sun, et al.
Frontiers in Oncology|August 28, 2020
Computed Tomography-Based Differentiation of Benign and Malignant Craniofacial Lesions in Neurofibromatosis Type I Patients: A Machine Learning ApproachCheng-Jiang Wei, Cheng Yan, Yan Tang, et al.
Neuro-Oncology Advances|July 10, 2020
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesisCheng-Jiang Wei, Shu-Chen Gu, Jie-Yi Ren, et al.
Pageof 2